<?xml version="1.0" encoding="UTF-8"?>
<ref id="B128-pharmaceuticals-12-00157">
 <label>128.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Julander</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Siddharthan</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Evans</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Taylor</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tolbert</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Apuli</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Stewart</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Collins</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gebre</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Neilson</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>137</volume>
  <fpage>14</fpage>
  <lpage>22</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.11.003</pub-id>
  <?supplied-pmid 27838352?>
  <pub-id pub-id-type="pmid">27838352</pub-id>
 </element-citation>
</ref>
